Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opiate Antagonist Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 0.4 mg/ml
1.2.3 1 mg/ml
1.2.4 2 mg/ml
1.3 Market by Application
1.3.1 Global Opiate Antagonist Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Pharmacy
1.3.5 Home
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opiate Antagonist Market Perspective (2018-2034)
2.2 Opiate Antagonist Growth Trends by Region
2.2.1 Global Opiate Antagonist Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Opiate Antagonist Historic Market Size by Region (2018-2023)
2.2.3 Opiate Antagonist Forecasted Market Size by Region (2024-2034)
2.3 Opiate Antagonist Market Dynamics
2.3.1 Opiate Antagonist Industry Trends
2.3.2 Opiate Antagonist Market Drivers
2.3.3 Opiate Antagonist Market Challenges
2.3.4 Opiate Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opiate Antagonist Players by Revenue
3.1.1 Global Top Opiate Antagonist Players by Revenue (2018-2023)
3.1.2 Global Opiate Antagonist Revenue Market Share by Players (2018-2023)
3.2 Global Opiate Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opiate Antagonist Revenue
3.4 Global Opiate Antagonist Market Concentration Ratio
3.4.1 Global Opiate Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opiate Antagonist Revenue in 2024
3.5 Opiate Antagonist Key Players Head office and Area Served
3.6 Key Players Opiate Antagonist Product Solution and Service
3.7 Date of Enter into Opiate Antagonist Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opiate Antagonist Breakdown Data by Type
4.1 Global Opiate Antagonist Historic Market Size by Type (2018-2023)
4.2 Global Opiate Antagonist Forecasted Market Size by Type (2024-2034)
5 Opiate Antagonist Breakdown Data by Application
5.1 Global Opiate Antagonist Historic Market Size by Application (2018-2023)
5.2 Global Opiate Antagonist Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Opiate Antagonist Market Size (2018-2034)
6.2 North America Opiate Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Opiate Antagonist Market Size by Country (2018-2023)
6.4 North America Opiate Antagonist Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opiate Antagonist Market Size (2018-2034)
7.2 Europe Opiate Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Opiate Antagonist Market Size by Country (2018-2023)
7.4 Europe Opiate Antagonist Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opiate Antagonist Market Size (2018-2034)
8.2 Asia-Pacific Opiate Antagonist Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Opiate Antagonist Market Size by Region (2018-2023)
8.4 Asia-Pacific Opiate Antagonist Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opiate Antagonist Market Size (2018-2034)
9.2 Latin America Opiate Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Opiate Antagonist Market Size by Country (2018-2023)
9.4 Latin America Opiate Antagonist Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opiate Antagonist Market Size (2018-2034)
10.2 Middle East & Africa Opiate Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Opiate Antagonist Market Size by Country (2018-2023)
10.4 Middle East & Africa Opiate Antagonist Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Opiate Antagonist Introduction
11.1.4 Pfizer Revenue in Opiate Antagonist Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Sun Pharmaceutical Industries
11.2.1 Sun Pharmaceutical Industries Company Detail
11.2.2 Sun Pharmaceutical Industries Business Overview
11.2.3 Sun Pharmaceutical Industries Opiate Antagonist Introduction
11.2.4 Sun Pharmaceutical Industries Revenue in Opiate Antagonist Business (2018-2023)
11.2.5 Sun Pharmaceutical Industries Recent Development
11.3 Teva Pharmaceuticals
11.3.1 Teva Pharmaceuticals Company Detail
11.3.2 Teva Pharmaceuticals Business Overview
11.3.3 Teva Pharmaceuticals Opiate Antagonist Introduction
11.3.4 Teva Pharmaceuticals Revenue in Opiate Antagonist Business (2018-2023)
11.3.5 Teva Pharmaceuticals Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Detail
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Opiate Antagonist Introduction
11.4.4 Cardinal Health Revenue in Opiate Antagonist Business (2018-2023)
11.4.5 Cardinal Health Recent Development
11.5 Baxter Pharmaceutical
11.5.1 Baxter Pharmaceutical Company Detail
11.5.2 Baxter Pharmaceutical Business Overview
11.5.3 Baxter Pharmaceutical Opiate Antagonist Introduction
11.5.4 Baxter Pharmaceutical Revenue in Opiate Antagonist Business (2018-2023)
11.5.5 Baxter Pharmaceutical Recent Development
11.6 Adapt Pharmaceuticals
11.6.1 Adapt Pharmaceuticals Company Detail
11.6.2 Adapt Pharmaceuticals Business Overview
11.6.3 Adapt Pharmaceuticals Opiate Antagonist Introduction
11.6.4 Adapt Pharmaceuticals Revenue in Opiate Antagonist Business (2018-2023)
11.6.5 Adapt Pharmaceuticals Recent Development
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Detail
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories Opiate Antagonist Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in Opiate Antagonist Business (2018-2023)
11.7.5 Dr. Reddy's Laboratories Recent Development
11.8 GIV Repack
11.8.1 GIV Repack Company Detail
11.8.2 GIV Repack Business Overview
11.8.3 GIV Repack Opiate Antagonist Introduction
11.8.4 GIV Repack Revenue in Opiate Antagonist Business (2018-2023)
11.8.5 GIV Repack Recent Development
11.9 Intl Medication Systems
11.9.1 Intl Medication Systems Company Detail
11.9.2 Intl Medication Systems Business Overview
11.9.3 Intl Medication Systems Opiate Antagonist Introduction
11.9.4 Intl Medication Systems Revenue in Opiate Antagonist Business (2018-2023)
11.9.5 Intl Medication Systems Recent Development
11.10 Kaleo Pharma
11.10.1 Kaleo Pharma Company Detail
11.10.2 Kaleo Pharma Business Overview
11.10.3 Kaleo Pharma Opiate Antagonist Introduction
11.10.4 Kaleo Pharma Revenue in Opiate Antagonist Business (2018-2023)
11.10.5 Kaleo Pharma Recent Development
11.11 Mylan Institutional
11.11.1 Mylan Institutional Company Detail
11.11.2 Mylan Institutional Business Overview
11.11.3 Mylan Institutional Opiate Antagonist Introduction
11.11.4 Mylan Institutional Revenue in Opiate Antagonist Business (2018-2023)
11.11.5 Mylan Institutional Recent Development
11.12 Perrigo Pharmaceuticals
11.12.1 Perrigo Pharmaceuticals Company Detail
11.12.2 Perrigo Pharmaceuticals Business Overview
11.12.3 Perrigo Pharmaceuticals Opiate Antagonist Introduction
11.12.4 Perrigo Pharmaceuticals Revenue in Opiate Antagonist Business (2018-2023)
11.12.5 Perrigo Pharmaceuticals Recent Development
11.13 AuroMedics Pharma
11.13.1 AuroMedics Pharma Company Detail
11.13.2 AuroMedics Pharma Business Overview
11.13.3 AuroMedics Pharma Opiate Antagonist Introduction
11.13.4 AuroMedics Pharma Revenue in Opiate Antagonist Business (2018-2023)
11.13.5 AuroMedics Pharma Recent Development
11.14 Somerset Pharma
11.14.1 Somerset Pharma Company Detail
11.14.2 Somerset Pharma Business Overview
11.14.3 Somerset Pharma Opiate Antagonist Introduction
11.14.4 Somerset Pharma Revenue in Opiate Antagonist Business (2018-2023)
11.14.5 Somerset Pharma Recent Development
11.15 Akorn
11.15.1 Akorn Company Detail
11.15.2 Akorn Business Overview
11.15.3 Akorn Opiate Antagonist Introduction
11.15.4 Akorn Revenue in Opiate Antagonist Business (2018-2023)
11.15.5 Akorn Recent Development
11.16 Alkermes
11.16.1 Alkermes Company Detail
11.16.2 Alkermes Business Overview
11.16.3 Alkermes Opiate Antagonist Introduction
11.16.4 Alkermes Revenue in Opiate Antagonist Business (2018-2023)
11.16.5 Alkermes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Opiate Antagonist Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of 0.4 mg/ml
Table 3. Key Players of 1 mg/ml
Table 4. Key Players of 2 mg/ml
Table 5. Global Opiate Antagonist Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Opiate Antagonist Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Opiate Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Opiate Antagonist Market Share by Region (2018-2023)
Table 9. Global Opiate Antagonist Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Opiate Antagonist Market Share by Region (2024-2034)
Table 11. Opiate Antagonist Market Trends
Table 12. Opiate Antagonist Market Drivers
Table 13. Opiate Antagonist Market Challenges
Table 14. Opiate Antagonist Market Restraints
Table 15. Global Opiate Antagonist Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Opiate Antagonist Market Share by Players (2018-2023)
Table 17. Global Top Opiate Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opiate Antagonist as of 2024)
Table 18. Ranking of Global Top Opiate Antagonist Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Opiate Antagonist Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Opiate Antagonist Product Solution and Service
Table 22. Date of Enter into Opiate Antagonist Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Opiate Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Opiate Antagonist Revenue Market Share by Type (2018-2023)
Table 26. Global Opiate Antagonist Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Opiate Antagonist Revenue Market Share by Type (2024-2034)
Table 28. Global Opiate Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Opiate Antagonist Revenue Market Share by Application (2018-2023)
Table 30. Global Opiate Antagonist Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Opiate Antagonist Revenue Market Share by Application (2024-2034)
Table 32. North America Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Opiate Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Opiate Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Opiate Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Opiate Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Opiate Antagonist Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Opiate Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Opiate Antagonist Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Opiate Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Opiate Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Opiate Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Opiate Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Opiate Antagonist Product
Table 50. Pfizer Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Sun Pharmaceutical Industries Company Detail
Table 53. Sun Pharmaceutical Industries Business Overview
Table 54. Sun Pharmaceutical Industries Opiate Antagonist Product
Table 55. Sun Pharmaceutical Industries Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 56. Sun Pharmaceutical Industries Recent Development
Table 57. Teva Pharmaceuticals Company Detail
Table 58. Teva Pharmaceuticals Business Overview
Table 59. Teva Pharmaceuticals Opiate Antagonist Product
Table 60. Teva Pharmaceuticals Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 61. Teva Pharmaceuticals Recent Development
Table 62. Cardinal Health Company Detail
Table 63. Cardinal Health Business Overview
Table 64. Cardinal Health Opiate Antagonist Product
Table 65. Cardinal Health Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 66. Cardinal Health Recent Development
Table 67. Baxter Pharmaceutical Company Detail
Table 68. Baxter Pharmaceutical Business Overview
Table 69. Baxter Pharmaceutical Opiate Antagonist Product
Table 70. Baxter Pharmaceutical Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 71. Baxter Pharmaceutical Recent Development
Table 72. Adapt Pharmaceuticals Company Detail
Table 73. Adapt Pharmaceuticals Business Overview
Table 74. Adapt Pharmaceuticals Opiate Antagonist Product
Table 75. Adapt Pharmaceuticals Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 76. Adapt Pharmaceuticals Recent Development
Table 77. Dr. Reddy's Laboratories Company Detail
Table 78. Dr. Reddy's Laboratories Business Overview
Table 79. Dr. Reddy's Laboratories Opiate Antagonist Product
Table 80. Dr. Reddy's Laboratories Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 81. Dr. Reddy's Laboratories Recent Development
Table 82. GIV Repack Company Detail
Table 83. GIV Repack Business Overview
Table 84. GIV Repack Opiate Antagonist Product
Table 85. GIV Repack Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 86. GIV Repack Recent Development
Table 87. Intl Medication Systems Company Detail
Table 88. Intl Medication Systems Business Overview
Table 89. Intl Medication Systems Opiate Antagonist Product
Table 90. Intl Medication Systems Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 91. Intl Medication Systems Recent Development
Table 92. Kaleo Pharma Company Detail
Table 93. Kaleo Pharma Business Overview
Table 94. Kaleo Pharma Opiate Antagonist Product
Table 95. Kaleo Pharma Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 96. Kaleo Pharma Recent Development
Table 97. Mylan Institutional Company Detail
Table 98. Mylan Institutional Business Overview
Table 99. Mylan Institutional Opiate Antagonist Product
Table 100. Mylan Institutional Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 101. Mylan Institutional Recent Development
Table 102. Perrigo Pharmaceuticals Company Detail
Table 103. Perrigo Pharmaceuticals Business Overview
Table 104. Perrigo Pharmaceuticals Opiate Antagonist Product
Table 105. Perrigo Pharmaceuticals Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 106. Perrigo Pharmaceuticals Recent Development
Table 107. AuroMedics Pharma Company Detail
Table 108. AuroMedics Pharma Business Overview
Table 109. AuroMedics Pharma Opiate Antagonist Product
Table 110. AuroMedics Pharma Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 111. AuroMedics Pharma Recent Development
Table 112. Somerset Pharma Company Detail
Table 113. Somerset Pharma Business Overview
Table 114. Somerset Pharma Opiate Antagonist Product
Table 115. Somerset Pharma Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 116. Somerset Pharma Recent Development
Table 117. Akorn Company Detail
Table 118. Akorn Business Overview
Table 119. Akorn Opiate Antagonist Product
Table 120. Akorn Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 121. Akorn Recent Development
Table 122. Alkermes Company Detail
Table 123. Alkermes Business Overview
Table 124. Alkermes Opiate Antagonist Product
Table 125. Alkermes Revenue in Opiate Antagonist Business (2018-2023) & (US$ Million)
Table 126. Alkermes Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opiate Antagonist Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Opiate Antagonist Market Share by Type: 2024 VS 2034
Figure 3. 0.4 mg/ml Features
Figure 4. 1 mg/ml Features
Figure 5. 2 mg/ml Features
Figure 6. Global Opiate Antagonist Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Opiate Antagonist Market Share by Application: 2024 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Home Case Studies
Figure 12. Others Case Studies
Figure 13. Opiate Antagonist Report Years Considered
Figure 14. Global Opiate Antagonist Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Opiate Antagonist Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Opiate Antagonist Market Share by Region: 2024 VS 2034
Figure 17. Global Opiate Antagonist Market Share by Players in 2024
Figure 18. Global Top Opiate Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opiate Antagonist as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Opiate Antagonist Revenue in 2024
Figure 20. North America Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Opiate Antagonist Market Share by Country (2018-2034)
Figure 22. United States Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Opiate Antagonist Market Share by Country (2018-2034)
Figure 26. Germany Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Opiate Antagonist Market Share by Region (2018-2034)
Figure 34. China Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Opiate Antagonist Market Share by Country (2018-2034)
Figure 42. Mexico Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Opiate Antagonist Market Share by Country (2018-2034)
Figure 46. Turkey Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Opiate Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 49. Sun Pharmaceutical Industries Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 50. Teva Pharmaceuticals Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 51. Cardinal Health Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 52. Baxter Pharmaceutical Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 53. Adapt Pharmaceuticals Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 55. GIV Repack Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 56. Intl Medication Systems Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 57. Kaleo Pharma Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 58. Mylan Institutional Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 59. Perrigo Pharmaceuticals Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 60. AuroMedics Pharma Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 61. Somerset Pharma Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 62. Akorn Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 63. Alkermes Revenue Growth Rate in Opiate Antagonist Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed